Fulgent Genetics, Inc.
FLGT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $323M | $283M | +13.8% |
| Operating income | −$91.1M | −$73.9M | −23.2% |
| Net income | −$60.5M | −$42.7M | −41.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $90.4M | $84.1M | +7.5% |
| Operating income | −$22.5M | −$15.3M | −47.1% |
| Net income | −$13.2M | −$6.60M | −100% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Fulgent Genetics's revenue in FY2025?
- $323M in FY2025 (Fiscal year ended Dec 31, 2025), +13.8% vs $283M a year earlier, per its 10-K filed Feb 2026.
- Was Fulgent Genetics profitable in FY2025?
- No: net income was −$60.5M and operating income −$91.1M in FY2025.
- What was Fulgent Genetics's revenue in Q3 2026?
- $90.4M (+7.5% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.